| Returns | 1W : 0.5% , 1M : 30.7%,1Y : 310.6% |
| Peers & Returns | 1W | 1M | 1Y |
| WINTAC LTD | 0.5% | 30.7% | 310.6% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 0.4% | 7% | 51.4% |
| DR REDDYS LABORATORIES LTD | -4.4% | -8.8% | 40% |
| DIVIS LABORATORIES LTD | -2.5% | -1.3% | 61.2% |
| CIPLA LTD | 0.2% | -3.9% | 83.5% |
| BIOCON LTD | -1.5% | 5.4% | 24.1% |
| AUROBINDO PHARMA LTD | -2.9% | -10% | 71.1% |
| LUPIN LTD | 0.2% | -4.7% | 49.7% |
| TORRENT PHARMACEUTICALS LTD | -1.3% | -6.9% | 14% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
-
P/E Calculated based on EPS of -3.05
[ Mar2020 - Standalone Results ] -
P/B Calculated based on Book Value of -8.15
[ Mar2020 - Standalone Results ] 3.51
P/S Calculated based on Revenues of 97.332 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA -19% -22% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
